Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy ...

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

Besides diabetes, obesity is a major risk factor for hypertension and heart disease, creating what can only be described as a ...

Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding demand has caused many to wonder if they are indeed the magical solution to ...

It helps regulate blood sugar levels and also has direct effects on fat metabolism ... Similar concerns arose for its oral weight-loss pill. Unsurprisingly, when it comes to developing weight ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

The Vanderpump Rules star, 34, appeared on a Tuesday, Dec. 31 episode of the Not Skinny But Not Fat podcast and spoke ... on her Instagram Stories of a pill bottle and explained her decision ...

There is only one GLP-1 pill on the market, and it's not as effective as Ozempic for weight loss.Grace Cary/Getty Images Eli Lilly competitor Novo Nordisk kicked off the weight-loss drug craze ...